Home / Recalls / Pharmacy Plus, Inc. dba Vital Care Compounder / D-0056-2023

D-0056-2023 Class II Ongoing

Recalled by Pharmacy Plus, Inc. dba Vital Care Compounder — Hattiesburg, MS

Recall Details

Product Type
Drugs
Report Date
November 9, 2022
Initiation Date
October 7, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12 syringes

Product Description

VANCOMYCIN INTRAVITREAL 1MG/0.1ML SOLUTION, 0.5 mL syringes, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

Reason for Recall

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Distribution Pattern

AL, LA, MS, and TN

Code Information

Lots: 65432, BUD: 10/13/2022; 66347, BUD: 11/05/2022; 66864, BUD: 11/18/2022

Other recalls by Pharmacy Plus, Inc. dba Vital Care Compounder

  • D-0538-2023 Class II — C-Semaglutide 5mg/mL injection, 0.5mL vials, Rx only, Vital Care Compounder 115 (April 13, 2023)
  • D-0036-2023 Class II — LIDOCAINE EPINEPHRINE BUFFERED 2%/1:1000 Solution, 10 mL syringe, Rx only, Vital (October 7, 2022)
  • D-0033-2023 Class II — GLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Care (October 7, 2022)
  • D-0040-2023 Class II — MOXIFLOXACIN PRESERVATIVE FREE SYR, 0.15 mg/0.1 mL, Sterile Solution, 1 mL syrin (October 7, 2022)
  • D-0057-2023 Class II — VORICONAZOLE OPTH SOLUTION 2% STERILE SOLN, 10 ML droptainer, Rx only, Vital Car (October 7, 2022)
  • D-0053-2023 Class II — SEMAGLUTIDE INJECTION 5MG/ML (0.25MG/0.05ML) SOLN, various amounts in unit dose (October 7, 2022)
  • D-0044-2023 Class II — PAPAVERINE / PHENTOLAMINE / PROSTAGLANDIN INJ 75MG/2.5MG/50MCG/ BOTTLE SOLUTION, (October 7, 2022)
  • D-0049-2023 Class II — PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150MG/5MG/10MCG/VIAL SOLUTION, 5 ML vi (October 7, 2022)
  • D-0027-2023 Class II — ACETYLCYSTEINE OPTH 5% Solution, 15 mL droptainers, Rx only, Vital Care Compound (October 7, 2022)
  • D-0031-2023 Class II — CEFUROXIME INTRAVITREAL SYR 1MG/0.1ML Solution in 1 mL syringe, Rx only, Vital C (October 7, 2022)